跳至主要内容
临床试验/NCT04721886
NCT04721886招募中早期 1 期

Interstitial Fluid Pressure Estimation in Breast Cancer Using 3D Subharmonic Signals From Contrast-Enhanced Ultrasound

Thomas Jefferson University1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2020年11月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
招募中
入组人数
25
试验地点
1
主要终点
Correlation between subharmonic aided pressure estimation (SHAPE) results and direct measurements of interstitial fluid pressure (IFP)

研究概览

简要总结

This clinical trial studies the use of contrast-enhanced ultrasound (CEUS) in estimating tissue pressure in patients with breast cancer. Diagnostic procedures, such as CEUS, may help estimate tissue pressure noninvasively.

详细描述

PRIMARY OBJECTIVE:

I. To determine if the 3-dimensional (3D) subharmonic aided pressure estimation (SHAPE) results can be used to estimate interstitial fluid pressures (IFPs) in breast tumor and its surrounding tissue.

SECONDARY OBJECTIVE:

I. To determine if the malignancy of breast tumor can be predicted by the 3D SHAPE results.

OUTLINE:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Provide signed and dated informed consent form
  • Be conscious, willing and able to comply with all study procedures and be available for the duration of the study
  • At least 21 years old
  • Be scheduled for a breast biopsy (Breast Imaging Reporting and Data System [BIRAD] 4, 4A, 4B, 4C or 5)
  • Patient with an at least 1 cm mass located at < 3 cm depth, approachable by 2.5 inch needle
  • Be medically stable as determined by the investigator
  • If a female of child-bearing potential, must have a negative urine pregnancy test within 24 hours prior to administration of Definity

排除标准

  • Females who are pregnant or nursing
  • Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example:
  • Patients on life support or in a critical care unit
  • Patients with unstable occlusive disease (e.g., crescendo angina)
  • Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia
  • Patients with uncontrolled congestive heart failure (New York Heart Association [NYHA] class IV)
  • Patients with recent cerebral hemorrhage
  • Patients who have undergone surgery within 24 hours prior to the study sonographic examination
  • Patients with known hypersensitivity or allergy to any component of Definity
  • Patients with unstable cardiopulmonary conditions or respiratory distress syndrome
  • Patients with uncontrollable emphysema, pulmonary vasculitis, pulmonary hypertension or a history of pulmonary emboli

研究组 & 干预措施

Diagnostic (CEUS)

Experimental

Patients undergo ultrasound without contrast. Patients then receive Definity IV over 15 minutes and undergo CEUS.

干预措施: Ultrasonsgraphy (Procedure)

Diagnostic (CEUS)

Experimental

Patients undergo ultrasound without contrast. Patients then receive Definity IV over 15 minutes and undergo CEUS.

干预措施: Perflutren Lipid Microcpheres (Drug)

Diagnostic (CEUS)

Experimental

Patients undergo ultrasound without contrast. Patients then receive Definity IV over 15 minutes and undergo CEUS.

干预措施: Contrast - Enhanced Ultrasound (Procedure)

结局指标

主要结局

Correlation between subharmonic aided pressure estimation (SHAPE) results and direct measurements of interstitial fluid pressure (IFP)

时间窗: At baseline

Pearson's correlation coefficients will be computed between SHAPE results and direct IFP measurements by Stryker compartment pressure monitoring system. A Pearson's correlation coefficient above 0.5 will be considered a successful outcome.

次要结局

  • Prediction of malignancy of breast tumor by the 3-dimensional subharmonic aided pressure estimation results(At baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验